Sprott Inc’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CS
Sprott Inc's IBB Position: Q1 2017 in Review
Sprott Inc sold out of iShares Biotechnology ETF (IBB) in Q1 2017, closing a stake of 9,000 shares — an estimated $796K sold.
Sprott Inc first reported a position in IBB in Q1 2015 and held it in 3 quarters. The position peaked at $2.09M in Q1 2016. 520 funds tracked by Wall St. Rank hold IBB as of Q1 2017.
- Sprott Inc reported no remaining iShares Biotechnology ETF position as of Q1 2017 after selling out during the quarter.
- Sprott Inc sold 9,000 iShares Biotechnology ETF shares in Q1 2017, an estimated $796K.
- Sprott Inc first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 3 quarters.
- Sprott Inc's iShares Biotechnology ETF position peaked at $2.09M in Q1 2016.
- 520 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2017.
Based on Sprott Inc's 13F filing for Q1 2017, filed 8 May 2017.